The IBD SmartSelect Composite Rating for Main Street Capital rose from 94 to 96 Thursday.
The revised score means the stock currently tops 96% of all other stocks in terms of key performance metrics and technical strength.
Main Street Capital is currently forming a flat base, with a 43.15 entry. Look for the stock to break out in volume at least 40% higher than normal.
See How IBD Helps You Make More Money In Stocks
The stock sports a 91 EPS Rating, meaning its recent quarterly and longer-term annual earnings growth tops 91% of all stocks.
Its Accumulation/Distribution Rating of D shows moderate selling by institutional investors over the last 13 weeks. Look for the rating to improve to at least a C or better.
The company reported 41% EPS growth for Q2. That marks three straight quarters of rising EPS performance. Top line growth came in at 50%, down from 51% in the prior quarter. The company's next quarterly report is expected on or around Nov. 2.
Main Street Capital holds the No. 9 rank among its peers in the Finance-Investment Management industry group. Ares Management, Blue Owl Capital and ArrowMark Financial are among the top 5 highly-rated stocks within the group.
Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks
